The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Azactam 2 g Powder for Solution for Injection or Infusion

2 gram(s) Powder for solution for injection/infusion

Bristol-Myers Squibb Pharmaceuticals ucPA0002/052/003

Main Information

Trade NameAzactam 2 g Powder for Solution for Injection or Infusion
Active SubstancesAztreonam
Strength2 gram(s)
Dosage FormPowder for solution for injection/infusion
Licence HolderBristol-Myers Squibb Pharmaceuticals uc
Licence NumberPA0002/052/003

Group Information

ATC CodeJ01DF Monobactams
J01DF01 aztreonam


Licence Issued05/03/1985
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back